【Editor's Choice | Genome Sequencing】
Upgraded Manufacturing Processes for Domestic Nucleic Acid and Peptide! Genomics Raises 4.88 Million in Seasoned Equity Offering
 
Genomics BioSci & Tech (4195.TWO) recently announced the early completion of its seasoned equity offering for year 2022, raising a total of USD $4.88 million.
 
CEO Kevin Chiang stated that this funding will be used for facility construction and operational enhancements, aiming to establish a GMP nucleic acid synthesis base in Taiwan through continuous optimization of nucleic acid and peptide manufacturing process.
 
He indicated that in the future, manufacturing process and quality standards for raw materials, adjuvants, peptides will meet pharmaceutical grade. Not only will this drive the transformation and upgrading of the company, but it will also contribute to enhancing Taiwan's international competitiveness in the nucleic acid industry.
 
Find more news and insights from GlobalBio's:
https://lnkd.in/erJs-b3C

#nucleicacid #peptide #genome #sequencing #genomics